NEW YORK (GenomeWeb) – Danaher today initiated its 2018 outlook, saying earnings per share is anticipated to be in the range of $3.50 to $3.60.

On an adjusted basis, EPS was guided to a range of $4.25 to $4.35, which assumes revenue growth of between 3.5 percent and 4 percent, the company said. The consensus Wall Street estimate for 2018 is for EPS of $4.34.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.